These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10952819)

  • 21. The viable myocardium: epidemiology, detection, and clinical implications.
    Marwick TH
    Lancet; 1998 Mar; 351(9105):815-9. PubMed ID: 9519973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic and therapeutic implications of myocardial viability in patients with heart failure.
    Soman P; Udelson JE
    Curr Cardiol Rep; 2004 May; 6(3):211-6. PubMed ID: 15075058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revascularization in severe left ventricular dysfunction: the role of viability testing.
    Chareonthaitawee P; Gersh BJ; Araoz PA; Gibbons RJ
    J Am Coll Cardiol; 2005 Aug; 46(4):567-74. PubMed ID: 16098417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial stunning in hyperthyroidism.
    Pereira N; Parisi A; Dec GW; Choo J; Hajjar R; Gordon PC
    Clin Cardiol; 2000 Apr; 23(4):298-300. PubMed ID: 10763082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy.
    Riedlbauchová L; Brunken R; Jaber WA; Popová L; Patel D; Lánská V; Civello K; Cummings J; Burkhardt JD; Saliba W; Martin D; Schweikert R; Wilkoff BL; Grimm R; Natale A
    J Cardiovasc Electrophysiol; 2009 Jan; 20(1):50-7. PubMed ID: 18803571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography and low-dose dobutamine echocardiography in the prediction of postrevascularization improvement in left ventricular function and exercise parameters.
    Wiggers H; Nielsen TT; Bøttcher M; Egeblad H; Bøtker HE
    Am Heart J; 2000 Dec; 140(6):928-36. PubMed ID: 11099997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy--a myriad of techniques.
    Galasko GI; Lahiri A
    Eur J Heart Fail; 2003 Jun; 5(3):217-27. PubMed ID: 12798818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization.
    Penicka M; Tousek P; De Bruyne B; Wijns W; Lang O; Madaric J; Vanderheyden M; Tintera J; Malý M; Widimsky P; Bartunek J
    Eur Heart J; 2007 Jun; 28(11):1366-73. PubMed ID: 17208936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic role of dobutamine stress echocardiography in myocardial viability.
    Schinkel AF; Poldermans D; Elhendy A; Bax JJ
    Curr Opin Cardiol; 2006 Sep; 21(5):443-9. PubMed ID: 16900006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise-induced ventricular dysfunction in hypertrophic cardiomyopathy: stunning by any other name?
    Ashrafian H; Watkins H
    Heart; 2008 Oct; 94(10):1251-3. PubMed ID: 18801785
    [No Abstract]   [Full Text] [Related]  

  • 31. Tako tsubo cardiomyopathy secondary to seizures.
    Weeks SG; Alvarez N; Pillay N; Bell RB
    Can J Neurol Sci; 2007 Feb; 34(1):105-7. PubMed ID: 17352357
    [No Abstract]   [Full Text] [Related]  

  • 32. Hibernating myocardium.
    Brown TA
    Am J Crit Care; 2001 Mar; 10(2):84-91; quiz 92-3. PubMed ID: 11244676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QT dispersion is determined by the relative extent of normal, hibernating, and scarred myocardium in patients with chronic ischemic cardiomyopathy. A dobutamine stress echocardiography study before and after surgical revascularization.
    Papadopoulos CE; Zaglavara T; Karvounis HI; Haaverstad R; Parharidis GE; Louridas GE; Kenny A
    J Electrocardiol; 2006 Jan; 39(1):103-9. PubMed ID: 16387061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of myocardial viability with cardiac magnetic resonance imaging.
    Ozben B; Cinçin AA; Mutlu B
    Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():71-6. PubMed ID: 19028638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Refractory heart failure. Myocardial revascularization as alternative to heart transplantation].
    Alfieri O; Mangia R
    Ital Heart J Suppl; 2002 Aug; 3(8):812-21. PubMed ID: 12407836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four left ventricular apical abnormalities.
    Conti CR
    Clin Cardiol; 2006 Feb; 29(2):50-1. PubMed ID: 16506637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hibernating myocardium in heart failure.
    Bhatia G; Sosin M; Leahy JF; Connolly DL; Davis RC; Lip GY
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):111-22. PubMed ID: 15723580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction.
    Schvartzman PR; Srichai MB; Grimm RA; Obuchowski NA; Hammer DF; McCarthy PM; Kasper JM; White RD
    Am Heart J; 2003 Sep; 146(3):535-41. PubMed ID: 12947375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hibernation and stunning: conditions with reversible left ventricular dysfunction].
    Hansen PR
    Ugeskr Laeger; 1997 Sep; 159(37):5537-9. PubMed ID: 9312926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling.
    Carluccio E; Biagioli P; Alunni G; Murrone A; Giombolini C; Ragni T; Marino PN; Reboldi G; Ambrosio G
    J Am Coll Cardiol; 2006 Mar; 47(5):969-77. PubMed ID: 16516079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.